Literature DB >> 12828709

Liposuction: a less invasive surgical method of debulking plexiform neurofibromas.

Srdan Babovic1, Uldis Bite, Pamela S Karnes, Dusica Babovic-Vuksanovic.   

Abstract

BACKGROUND: Neurofibromatosis type 1 (NF1) is a common autosomal dominant disorder in humans. The hallmark of NF1 is development of neural tumors. Plexiform neurofibromas are a major source of morbidity associated with NF1. Surgical removal of these particular tumors is associated with a high risk of damage of surrounding vital structures as well as a risk of significant hemorrhage. Surgical debulking of tumors also sometimes leads to extensive scarring, which may be very disfiguring. OBJECTIVE AND METHODS: We report a novel approach to the surgical therapy of plexiform neurofibromas using liposuction in two patients.
RESULTS: Debulking of plexiform neurofibromas with liposuction was successful in both patients. Postoperative follow-up 6 months later showed no evidence of tumor regrowth in either case.
CONCLUSION: Liposuction may be a preferable surgical method for debulking of superficial plexiform neurofibromas in patients with NF1. This method is less invasive than conventional surgical tumor debulking.

Entities:  

Mesh:

Year:  2003        PMID: 12828709     DOI: 10.1046/j.1524-4725.2003.29199.x

Source DB:  PubMed          Journal:  Dermatol Surg        ISSN: 1076-0512            Impact factor:   3.398


  3 in total

1.  Midline cutaneous lumbosacral lesions: not always a sign of occult spinal dysraphism.

Authors:  Juan F Martínez-Lage; Belen Ferri Niguez; Miguel A Pérez-Espejo; María J Almagro; Concepción Maeztu
Journal:  Childs Nerv Syst       Date:  2006-02-01       Impact factor: 1.475

2.  Surgery for Peripheral Nerve Sheath Tumours of the Buttocks, Legs and Feet in 90 Patients With Neurofibromatosis Type 1.

Authors:  Reinhard E Friedrich; Caglayan T Tuzcu
Journal:  In Vivo       Date:  2021 Mar-Apr       Impact factor: 2.155

3.  A qualitative study of the impact of plexiform neurofibromas on need fulfilment in adults with neurofibromatosis type 1.

Authors:  Alice Heaney; Jeanette Wilburn; Shannon Langmead; Jaishri Blakeley; Susan Huson; Carly Jim; Stephen P McKenna
Journal:  SAGE Open Med       Date:  2019-02-11
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.